Leveling the Playing Field: Overcoming Barriers to Equitable Care in ILD
More than 200 interstitial lung diseases (ILD) — from rare to relatively common – are now recognized in the United States, with most forms characterized by inflammation or fibrosis within the interstitial space. While the past several years have brought significant advances in management, the timely implementation of contemporary diagnostic and therapeutic pathways has been inconsistent by clinicians, partly due to a lack of coordinated, multidisciplinary care. Moreover, disparities in screening and treatment for patients with ILD further impedes the achievement of optimal clinical outcomes, including improved quality of life.
In this live, case-based CME Outfitters activity, a panel of experts in ILD explores strategies for implementing equitable, multidisciplinary care for all patients with ILD. The critical roles of assessing social determinants of health, engaging in shared decision-making with patients, and evaluating potential implicit bias are among the topics covered in this important initiative.
Live Webcast: Wednesday, August 9th, 2023
6:30 PM - 7:30 PM ET
This activity offers CE credit for:
Interprofessional (IPCE) 1.0
Physicians (ACCME) 1.0
Nurses (ANCC) 1.0
PAs (AAPA) 1.0
Royal College MOC
Pharmacists/Pharmacy Tech (ACPE) 1.0
MIPS Improvement Activity
Credit Expiration Date: 08/09/2024
By entering your mobile phone number you agree that CME Outfitters can send you periodic text messages about CME/CE activities. This free service is FCC CAN-SPAM compliant. You may update message preferences or unsubscribe at any time. Check your wireless provider for any message and data rates that may apply.
At the end of this CME/CE activity, participants should be able to:
- Implement timely screening strategies that support accurate diagnosis, focused patient education, and appropriate referrals for patients with ILD.
- Develop multidisciplinary treatment pathways for the care of patients with ILD that include lifestyle modifications, pharmacotherapies, referrals, and management of comorbidities.
- Incorporate shared decision-making (SDM) with patients that factors in recognizing SDoH and equitable care opportunities.
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Internists, primary care clinicians, pulmonologists, radiologists, infectious disease specialists, pathologists, nurse practitioners (NPs), physician associates (PAs), pharmacists, and other health care practitioners (HCPs) involved in the care and coordination of diverse populations of patients with ILD.